FDANonrulemakingFDA-2024-D-1461
Who commented on this docket
Content and Format of Composition Statement and Corresponding Statement of Ingredients in Labeling in NDAs and ANDAs; Draft Guidance for Industry; Availability
1 organizations filed 1 public comment on Content and Format of Composition Statement and Corresponding Statement of Ingredients in Labeling in NDAs and ANDAs; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 760d ago.
Organizations
1
Comments
1
RIN
—
Comment window
closed 760d ago
Commenters (1)
- Association for Accessible Medicinestrade assoc.1 filing · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.